SPRINGER TIMOTHY A
SEC CIK 1055624 · EDGAR
BoughtSold
Most active insiders at RNAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BARABE TIMOTHY C | Dir | $205.8K | — |
| 2 | Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| 3 | Davis Blaine | CFO | — | $72.2K |
| 4 | Miljkovic Milos | Chief Medical Off | — | $24.4K |
| 5 | Bot Adrian Ion | Dir | — | — |
| 6 | Seymour June Ann | CAO | — | — |
| 7 | English Emily | Chief Ops Off | — | — |
| 8 | Hoge Elizabeth | 10% | — | — |
| 9 | Singer Michael | Dir | — | — |
| 10 | Kalayoglu Murat | Dir, 10% | — | — |
| 14 | SPRINGER TIMOTHY A | Dir, 10% | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +2,600 | 8.65M | +0.0% | $0 |
| MI | 2025-04-11 | 2025-04-09+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $10.21 | +126.7K | 656.5K | +24% | +$1.29M |
| M | 2025-04-11 | 2025-04-09+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $10.21 | +22.4K | 8.63M | +0.3% | +$228.3K |
| M | 2025-04-11 | 2025-04-09+ | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $16.20 | +21.3K | 4.33M | +0.5% | +$344.8K |
| MI | 2025-04-11 | 2025-04-09+ | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $16.20 | +120.6K | 1.40M | +9% | +$1.95M |
| I | 2025-04-09 | 2025-04-07 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.10 | +412.5K | 1.38M | +43% | +$7.05M |
| 2025-04-09 | 2025-04-07 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.10 | +87.5K | 4.31M | +2% | +$1.50M | |
| M | 2025-03-20 | 2025-03-18+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $15.26 | +89.9K | 8.57M | +1% | +$1.37M |
| 2025-02-07 | 2025-02-05 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $54.14 | +129.3K | 4.23M | +3% | +$7.00M | |
| I | 2025-02-07 | 2025-02-05 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $50.00 | +660.0K | 970.2K | +213% | +$33.00M |
| M | 2025-01-15 | 2025-01-13+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.47 | +21.0K | 8.53M | +0.2% | +$366.4K |
| D | 2025-01-06 | 2025-01-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +2,600 | 8.51M | +0.0% | $0 |
| M | 2024-12-23 | 2024-12-19+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $18.49 | +52.2K | 8.51M | +0.6% | +$965.0K |
| M | 2024-11-18 | 2024-11-14+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $17.07 | +431.9K | 8.46M | +5% | +$7.37M |
| 2024-10-24 | 2024-10-22 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $33.59 | +300.0K | 4.10M | +8% | +$10.08M | |
| DM | 2024-10-04 | 2024-10-02+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $20.87 | +205.7K | 7.86M | +3% | +$4.29M |
| DMI | 2024-10-04 | 2024-10-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | J - Other | — | -1.80M | 529.8K | -77% | — |
| D | 2024-10-04 | 2024-10-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | J - Other | — | +1.80M | 7.82M | +30% | — |
| M | 2024-09-27 | 2024-09-25 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 6.02M | New | — |
| MI | 2024-09-27 | 2024-09-25 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 12.8K | New | — |
| M | 2024-09-26 | 2024-09-26 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $28.82 | +50.0K | 3.79M | +1% | +$1.44M |
| 2024-09-26 | 2024-09-24 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | J - Other | $0.00 | +1.05M | 3.75M | +39% | $0 | |
| MI | 2024-09-26 | 2024-09-24 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | J - Other | $0.00 | -1.05M | 310.2K | -77% | $0 |
| I | 2024-08-14 | 2024-08-12 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $12.72 | +8,016 | 11.5K | +229% | +$102.0K |
| MI | 2024-07-05 | 2024-07-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $20.00 | +722.7K | 1,307 | New | +$14.45M |
| 2024-07-05 | 2024-07-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $20.00 | +1.64M | 1.64M | New | +$32.74M | |
| D | 2024-06-24 | 2024-06-20 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | — | +2.69M | 2.69M | New | — |
| DI | 2024-06-24 | 2024-06-20 | TECX | Tectonic Therapeutic, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | — | +1.55M | 1.55M | New | — |
| MI | 2024-04-10 | 2024-04-08 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | +801.4K | 0 | New | — |
| M | 2024-04-10 | 2024-04-08 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | +4.01M | 0 | New | — |
| MI | 2024-03-28 | 2024-01-17+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.6202 | +18.4K | 97.6K | +23% | +$11.4K |
| DI | 2024-03-26 | 2024-03-26 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | $1.46 | +1.97M | 33.04M | +6% | +$2.88M |
| I | 2024-03-20 | 2024-03-18 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.6 | +19.0K | 31.07M | +0.1% | +$11.4K |
| MI | 2024-03-18 | 2024-03-14+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $0.5627 | +1.19M | 30.52M | +4% | +$667.2K |
| D | 2024-01-04 | 2024-01-02 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $0.00 | +178.0K | 7.47M | +2% | $0 |
| DI | 2023-11-15 | 2023-11-15 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $403.47 | +24.8K | 24.8K | New | +$10.00M |
| D | 2023-11-15 | 2023-11-15 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $403.47 | +123.9K | 123.9K | New | +$50.00M |
| DI | 2022-04-13 | 2022-04-11 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | — | +6.68M | 29.87M | +29% | — |
| I | 2021-12-17 | 2021-12-15 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $2.99 | +211.2K | 23.19M | +0.9% | +$631.5K |
| MI | 2021-12-13 | 2021-12-09+ | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $3.06 | +3.82M | 22.98M | +20% | +$11.69M |
Purchase Sale Sale after option exercise All abbreviations